|
業務類別
|
Biotechnology |
|
業務概覽
|
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States. |
| 公司地址
| Zernikedreef 9, Leiden, ZH, NLD, 2333 CK |
| 電話號碼
| +31 881667000 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.proqr.com |
| 員工數量
| 186 |
| Dr. Cristina Lopez Lopez, M.D.,PhD |
Chief Medical Officer |
-- |
12/03/2026 |
| Mr. Dennis Hom |
Chief Financial Officer |
-- |
12/03/2026 |
| Dr. Gerard Platenburg, PhD |
Chief Scientific Officer and and Director |
-- |
12/03/2026 |
| Mr. Daniel de Boer |
Chief Executive Officer and Director |
-- |
12/03/2026 |
| Ms. Sheila Sponselee |
Chief People and Chief Operations Officer |
-- |
12/03/2026 |
|
|
| Dr. Martin Maier, PhD |
Independent Director |
12/03/2026 |
| Dr. Begona Carreno, PhD |
Independent Director |
12/03/2026 |
| Dr. Gerard Platenburg, PhD |
Chief Scientific Officer and and Director |
12/03/2026 |
| Mr. Daniel de Boer |
Chief Executive Officer and Director |
12/03/2026 |
| Dr. Dinko Valerio, PhD |
Independent Director |
12/03/2026 |
| Ms. Alison F. Lawton |
Independent Director |
12/03/2026 |
| Mr. Bart Filius, M.B.A. |
Independent Director |
12/03/2026 |
| Dr. James S. Shannon, M.D.,M.R.C.P. |
Chairman of the Board |
12/03/2026 |
| Ms. Theresa M. Heggie |
Independent Director |
12/03/2026 |
|
|
|
|
